CIBASA AND ARTEMIS SIGN AGREEMENT FOR MARKETING OF CANCER STEM CELL TECHNOLOGY FOR DRUG RESEARCH

A A

Artemis Pharmaceuticals GmbH (Cologne, Germany) and the Center for Applied Molecular Research Salamanca (CIBASA), a Spanish biotechnology company, today announced the signing of a worldwide marketing agreement. Under the terms of the contract Artemis and CIBASA will collaborate in marketing CIBASA's groundbreaking Cancer Stem Cell (CSC) based Oncostem(TM) technology to pharmaceutical and biotechnology companies for the discovery and development of novel anti-cancer therapies.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/ed70ce88190619584f57ca501244778c.html)